How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,334 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. The Computerized Adaptive Diagnostic Test for Major Depressive Disorder (CAD-MDD): a screening tool for depression. (Full text)

The Computerized Adaptive Diagnostic Test for Major Depressive Disorder (CAD-MDD): a screening tool for depression. To develop a computerized adaptive diagnostic screening tool for depression that decreases patient and clinician burden and increases sensitivity and specificity for clinician-based DSM-IV diagnosis of major depressive disorder (MDD).656 individuals with and without minor and major depression were recruited from a psychiatric clinic and a community mental health center and through (...) public announcements (controls without depression). The focus of the study was the development of the Computerized Adaptive Diagnostic Test for Major Depressive Disorder (CAD-MDD) diagnostic screening tool based on a decision-theoretical approach (random forests and decision trees). The item bank consisted of 88 depression scale items drawn from 73 depression measures. Sensitivity and specificity for predicting clinician-based Structured Clinical Interview for DSM-IV Axis I Disorders diagnoses of MDD

2013 Journal of Clinical Psychiatry PubMed abstract

182. Validation of screening tools for antenatal depression in Malawi-A comparison of the Edinburgh Postnatal Depression Scale and Self Reporting Questionnaire. (Abstract)

Validation of screening tools for antenatal depression in Malawi-A comparison of the Edinburgh Postnatal Depression Scale and Self Reporting Questionnaire. The detection of antenatal depression in resource-limited settings such as Malawi, Africa, is important and requires an accurate and practical screening tool. It is not known which questionnaire would be most suitable for this purpose.A rigorously translated and modified Chichewa version of the Edinburgh Postnatal Depression Scale (EPDS (...) ).Inter-rater reliability testing was not done. The relatively small sample size resulted in wide confidence intervals around AUCs. The study was conducted amongst antenatal clinic attenders only, limiting generalisability to all pregnant women in this setting.The Chichewa versions of the EPDS and SRQ both show utility as brief screening measures for detection of antenatal depression in rural Malawi.© 2013 Elsevier B.V. All rights reserved.

2013 Journal of Affective Disorders

183. Identifying postnatal depression: Comparison of a self-reported depression item with Edinburgh Postnatal Depression Scale scores at three months postpartum. (Full text)

Identifying postnatal depression: Comparison of a self-reported depression item with Edinburgh Postnatal Depression Scale scores at three months postpartum. Early identification of postnatal depression is important in order to minimize adverse outcomes. The Edinburgh Postnatal Depression Scale (EPDS) is commonly used as a screening tool but a single, direct question on depression may offer an alternative means of identifying women in need of support. This study examines the agreement between (...) . The absence of a diagnostic interview limits conclusions on accuracy or internal validity of the measures.A direct question about postnatal depression may offer a valuable addition to screening tools to identify women in need of support.Copyright © 2019. Published by Elsevier B.V.

2019 Journal of Affective Disorders PubMed abstract

184. Tools to aid the clinical identification of end of life

). It is reproduced for general information and third parties rely upon it at their own risk. Tools to aid clinical identification of end of life An Evidence Check rapid review brokered by the Sax Institute for the Agency for Clinical Innovation. March 2017. This report was prepared by Health Policy Analysis Contents 1 Executive summary 5 Review questions 5 2 Introduction 7 Review questions 7 Scope/definitions 7 Search strategy and screening criteria 9 Information abstracted 12 3 Overview of included studies 14 (...) inputs. Others can be implemented on paper without complicated scoring. Some tools are based on screening clinical, practice or hospital databases. • How long does the tool take to complete? Ideally, for clinical practice, the relevant tools should be able to be completed quickly. The time taken to complete a tool was not specified in almost all the studies examined. • Is the tool aligned with other clinical assessments/ measures that are usually undertaken in the particular clinical setting

2018 Sax Institute Evidence Check

185. The Geriatric Depression Scale is the best screening tool for depression in older people in acute hospital settings

The Geriatric Depression Scale is the best screening tool for depression in older people in acute hospital settings The Geriatric Depression Scale is the best screening tool for depression in older people in acute hospital settings Search National Elf Service Search National Elf Service » » » » The Geriatric Depression Scale is the best screening tool for depression in older people in acute hospital settings Jan 19 2012 Posted by Depression often occurs in later life and people in poor physical (...) condition tend to be more susceptible than others. Older people in hospital who get depressed have poorer outcomes, so it’s important that we know how to detect depression and manage it in the acute setting. This systematic review conducted by researchers in Swansea set out to review all of the screening tools for detecting depression in older people in general hospitals. They conducted a decent search but only found 14 studies to include in their review. They concluded that only one screening

2012 The Mental Elf

186. Applying deep neural networks to unstructured text notes in electronic medical records for phenotyping youth depression (Full text)

Applying deep neural networks to unstructured text notes in electronic medical records for phenotyping youth depression Applying deep neural networks to unstructured text notes in electronic medical records for phenotyping youth depression | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Applying deep neural networks to unstructured text notes in electronic medical records for phenotyping youth depression Article Text Original article

2017 Evidence-Based Mental Health PubMed abstract

187. Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-an (Full text)

Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-an The 30-item Geriatric Depression Scale (GDS-30) and the shorter GDS-15, GDS-5 and GDS-4 are recommended as depression screening tools for elderly individuals. Existing meta-analyses on the diagnostic accuracy of the GDS have not been able (...) to conduct subgroup analyses, have included patients already identified as depressed who would not be screened in practice and have not accounted for possible bias due to selective reporting of results from only better-performing cut-offs in primary studies. Individual participant data meta-analysis (IPDMA), which involves a standard systematic review, then a synthesis of individual participant data, rather than summary results, could address these limitations. The objective of our IPDMA is to generate

2018 BMJ open PubMed abstract

188. Online screening for depression: Here’s what one physician thinks about it

, I see two different issues. The first is whether the 9-question Patient Health Questionnaire (PHQ-9) is an appropriate tool to use to screen for depression. The second is whether the public should trust Google to administer the PHQ-9. Before I do delve into that, though, let’s take a step back and consider the purpose of screening tools. Screening tools help physicians figure out how much more we should learn about a person. For example, asking for a person’s biological sex is a screening tool (...) interest in changing his smoking behaviors. Screening tools help us sort and gather information to generate diagnoses and interventions. The literature states that . The PHQ-9 was modeled after the criteria for major depression in DSM-IV. Thus, the problems with the PHQ-9 for diagnosis are the same as the problems with the DSM for diagnosis: Context is completely missing. The authors of DSM argue that the situation and underlying causes of major depression don’t matter; they state that the presence

2017 KevinMD blog

189. The Bipolar II Depression Questionnaire: A Self-Report Tool for Detecting Bipolar II Depression (Full text)

The Bipolar II Depression Questionnaire: A Self-Report Tool for Detecting Bipolar II Depression Bipolar II (BP-II) depression is often misdiagnosed as unipolar (UP) depression, resulting in suboptimal treatment. Tools for differentiating between these two types of depression are lacking. This study aimed to develop a simple, self-report screening instrument to help distinguish BP-II depression from UP depressive disorder. A prototype BP-II depression questionnaire (BPIIDQ-P) was constructed (...) at the secondary care level with satisfactory to good reliability and validity. It has good potential as a screening tool for BP-II depression in primary care settings. Recall bias, the relatively small sample size, and the high proportion of females in the BP-II sample limit the generalization of the results.

2016 PloS one PubMed abstract

190. Screening and Management of Late and Long-term Consequences of Myeloma and its Treatment

Monitoring levels of vitamin D, calcium Annually Screening for hypogonadism in males Annual serum morning testosterone, sex-hormone-binding globulin and gonadotrophins in patients post-HSCT or if symptomatic Screening for menopausal symptoms in females 75 years At baseline Psychological wellbeing Consider routine HNA to identify individual patient needs and concerns At the start and end of each line of treatment, or annually Mental health and wellbeing (mood/ anxiety/clinical depression) – assessment (...) Screening and Management of Late and Long-term Consequences of Myeloma and its Treatment Guidelines for screening and management of late and long-term consequences of myeloma and its treatment John A. Snowden,Writing Group Chair 1,2 Diana M. Green?eld, 2,3 Jennifer M. Bird, 4 Elaine Boland, 5 Stella Bowcock, 6 Abigail Fisher, 7 Eric Low, 8 Monica Morris 8 and Kwee Yong, 7 Guy Pratt 9 on behalf of the UK Myeloma Forum (UKMF) and the British Society for Haematology (BSH). 1 Department

2017 British Committee for Standards in Haematology

191. Final recommendation statement: obesity in children and adolescents: screening.

orthopedic pain, sleep apnea, or asthma; improved quality of life, functioning, or depression; avoidance of adult obesity), intermediate cardiometabolic outcomes (blood pressure, lipid, insulin/glucose measures), and adverse effects of screening or treatment (e.g., labeling, stigma or increased body image concerns, eating disorder, exercise-induced injury). Outcomes other than harms had to be reported at a minimum of 6 months after randomization; 12 months was the preferred outcome point. See (...) . Harms of Detection and Early Intervention or Treatment The U.S. Preventive Services Task Force (USPSTF) found adequate evidence to bound the harms of screening and comprehensive, intensive behavioral interventions for obesity in children and adolescents as small to none, based on the likely minimal harms of using body mass index (BMI) as a screening tool, the absence of reported harms in the evidence on behavioral interventions, and the noninvasive nature of the interventions. Evidence on the harms

2017 National Guideline Clearinghouse (partial archive)

192. Final recommendation statement: vision in children ages 6 months to 5 years: screening.

, poor visual motor skills, depression and anxiety, poor self-esteem, and problems at school and work. Current Practice Vision screening is routinely offered in most primary care settings. Screening rates among children aged 3 years are approximately 40% and increase with age. One survey reported that 3% of pediatricians began vision screening at age 6 months. Typical components of vision screening include assessments of visual acuity and strabismus. Younger children (<3 years) are often unable (...) Final recommendation statement: vision in children ages 6 months to 5 years: screening. Final recommendation statement: vision in children ages 6 months to 5 years: screening. | National Guideline Clearinghouse success fail May JUN 09 2017 2018 2019 19 May 2018 - 12 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites

2017 National Guideline Clearinghouse (partial archive)

193. Screening for Cognitive Impairment in Older Adults

is insufficient, clinicians should remain alert to early signs or symptoms of cognitive impairment (for example, problems with memory or language) and evaluate as appropriate. The National Institute on Aging has information on the detection and management of cognitive impairment for patients and clinicians, including a database of tools to detect cognitive impairment (available at ). Screening Tests Screening tests for cognitive impairment in the clinical setting generally include asking patients to perform (...) effect on cognitive function measures in the short term for patients with mild to moderate dementia, but the magnitude of the clinically relevant benefit is uncertain. The USPSTF found adequate evidence that interventions targeted to caregivers have a small effect on measures of caregiver burden and depression, but the magnitude of the clinically relevant benefit is uncertain. The USPSTF found no published evidence on the effect of screening on decision making or planning by patients, clinicians

2017 National Guideline Clearinghouse (partial archive)

194. Screening for Atrial Fibrillation: 2017 European Heart Rhythm Association (EHRA) Consensus Document

to differentiate atrial flutter 1596 G.H. Mairesse et al. Downloaded from https://academic.oup.com/europace/article-abstract/19/10/1589/3925674 by guest on 08 December 2017Figure2 Screening tools. Screening for atrial fibrillation: EHRA consensus document 1597 Downloaded from https://academic.oup.com/europace/article-abstract/19/10/1589/3925674 by guest on 08 December 2017from sinus tachycardia on the basis of a single lead recording corres- ponding to lead I. Therefore, automatic algorithms capable to effi (...) , systematic screening in higher risk groups may even be warranted. Detection of and screening of silent AF has been simplified thanks to the development of easy to use handheld and implantable devices. Guidelines evolution in the last 4 years is sum- marized inTable5. For a screening program to be efficient, high positive predictive val- ues achieved at low cost using a low-risk tool is required (Figures 4 and 5). The screening yield depends on the prevalence of the disease and the diagnostic performance

2017 Heart Rhythm Society

195. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents

and adolescents in the outpatient setting. This guideline is endorsed by the American Heart Association. When it was not possible to identify sufficient evidence, recommendations are based on the consensus opinion of the expert members of the Screening and Management of High Blood Pressure in Children Clinical Practice Guideline Subcommittee (henceforth, “the subcommittee”). The subcommittee intends to regularly update this guideline as new evidence becomes available. Implementation tools for this guideline (...) is designed as a screening tool only for the identification of children and adolescents who need further evaluation of their BP starting with repeat BP measurements. It should not be used to diagnose elevated BP or HTN by itself. To diagnose elevated BP or HTN, it is important to locate the actual cutoffs in the complete BP tables because the SBP and DBP cutoffs may be as much as 9 mm Hg higher depending on a child’s age and length or height. A typical-use case for this simplified table is for nursing

2017 American Academy of Pediatrics

196. Obesity in Children and Adolescents: Screening

of screening and comprehensive, intensive behavioral interventions for obesity in children and adolescents as small to none, based on the likely minimal harms of using BMI as a screening tool, the absence of reported harms in the evidence on behavioral interventions, and the noninvasive nature of the interventions. Evidence on the harms associated with metformin is inadequate. Adequate evidence shows that orlistat has moderate harms, including abdominal pain or cramping, flatus with discharge, fecal (...) scores. Five of these trials reported on self-esteem outcomes, and 5 reported on body satisfaction outcomes; no between-group differences were found. One trial reported no group differences in the percentage of participants screening positive for depression. No trials reported on other health outcomes, such as morbidity associated with type 2 diabetes or hypertension, orthopedic pain, sleep apnea, or adult obesity. The remaining 3 small trials, which either did not consist of multiple components

2017 U.S. Preventive Services Task Force

197. Vision in Children Ages 6 Months to 5 Years: Screening

of vision abnormalities could prevent the development of amblyopia. Detection The USPSTF found adequate evidence that vision screening tools are accurate in detecting vision abnormalities, including refractive errors, strabismus, and amblyopia. The USPSTF found inadequate evidence to compare screening accuracy across age groups (<3 vs ≥3 years). Many studies of clinical accuracy did not enroll children younger than 3 years. Benefits of Early Detection and Treatment The USPSTF found adequate evidence (...) . , , Untreated vision abnormalities can result in short- and long-term physical and psychological harms, such as accidents and injuries, experiencing bullying behaviors, poor visual motor skills, depression and anxiety, poor self-esteem, and problems at school and work. Current Practice Vision screening is routinely offered in most primary care settings. Screening rates among children aged 3 years are approximately 40% and increase with age. , One survey reported that 3% of pediatricians began vision

2017 U.S. Preventive Services Task Force

198. The validity of the hospital anxiety and depression scale and the geriatric depression scale-5 in home-dwelling old adults in Norway<sup>✰</sup>. (Abstract)

talked through the self-filling questionnaires. The procedure could have influenced the participants' answers.GDS-5 and HADS-D are useful screening tools for old adults, but only fairly good to identify depression according to criteria of ICD-10.Copyright © 2019. Published by Elsevier B.V. (...) The validity of the hospital anxiety and depression scale and the geriatric depression scale-5 in home-dwelling old adults in Norway. Little is known about the validity of the Norwegian versions of the Geriatric Depression Scale-5 (GDS-5) and the Hospital Anxiety and Depression Scale-D (HADS-D). The aim of this study was therefor to validate the two assessment tools in a population of home-dwelling persons of 60 years of age and above.A sample of 194 home-dwelling old adults

2019 Journal of Affective Disorders

199. Usefulness of the 15-item geriatric depression scale (GDS-15) for classifying minor and major depressive disorders among community-dwelling elders. (Full text)

Usefulness of the 15-item geriatric depression scale (GDS-15) for classifying minor and major depressive disorders among community-dwelling elders. The 15-item geriatric depression scale (GDS-15) is a short form of GDS and is used to screen, diagnose, and evaluate depression in elderly individuals. Most previous studies evaluated the ability of GDS-15 to discriminate between depressive and non-depressive states. In this study, we investigated the multi-stage discriminating ability of GDS-15 (...) with mild cognitive impairment.GDS-15 was a useful tool to classify stages of geriatric depression into either minor or major depressive disorder.Copyright © 2019 Elsevier B.V. All rights reserved.

2019 Journal of Affective Disorders PubMed abstract

200. Epidemiology of depressive disorders in people living with HIV in Africa: a systematic review and meta-analysis: Burden of depression in HIV in Africa. (Abstract)

of depressive disorders was significantly explained by screening tool used, period (higher prevalence in recent studies) and distribution in sub-regions. The study setting, site, CD4 cell counts, age, sex, proportion of people with undetectable viral load were not sources of heterogeneity.This study shows that more than one third of PLHIV face depressive disorders and half of them having major form, with heterogeneous distribution in the continent. As such, depressive disorders deserve more attention from (...) Epidemiology of depressive disorders in people living with HIV in Africa: a systematic review and meta-analysis: Burden of depression in HIV in Africa. The burden of HIV infection is higher in Africa where 70% of people living with HIV (PLHIV) resides. Since depression can negatively impact the course of HIV infection, it is therefore important to accurately estimate its burden among PLHIV in the continent.We searched multiple databases to identify articles published between January 2000

2019 General hospital psychiatry

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>